Pediatrix Medical (MD) Short term Debt (2009 - 2026)

Pediatrix Medical has disclosed Short term Debt across 14 years of filings, most recently posting $192.4 million for Q1 2026.

• In Q1 2026, Short term Debt rose 769.58% year-over-year to $192.4 million; the TTM figure through Mar 2026 stood at $192.4 million (up 769.58% YoY), while the FY2025 annual figure was $26.8 million, up 30.47% from the prior year.
• Short term Debt climbed to $192.4 million in Q1 2026, from $26.8 million in the prior quarter.
• Over the last five years, Short term Debt for MD reached as high as $192.4 million in Q1 2026 and fell as low as $14.9 million in Q4 2022.
• The 5-year median for Short term Debt is $17.1 million (2024), against an average of $29.3 million.
• Annual changes were most pronounced in 2023 — Short term Debt declined 0.02% — and 2026, when it surged 769.58%.
• A 5-year view of Short term Debt shows it stood at $14.9 million in 2022, then rose by 0.1% to $14.9 million in 2023, then jumped by 37.77% to $20.5 million in 2024, then soared by 30.47% to $26.8 million in 2025, then jumped by 617.83% to $192.4 million in 2026.
• According to Business Quant data, Short term Debt over the past three periods registered $192.4 million, $26.8 million, and $25.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.